X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (161) 161
index medicus (126) 126
oncology (125) 125
cancer (97) 97
chemotherapy (92) 92
female (76) 76
patients receiving chemotherapy (76) 76
double-blind (70) 70
neutropenia (64) 64
male (63) 63
colony-stimulating factor (59) 59
antineoplastic agents - adverse effects (58) 58
neoplasms - drug therapy (57) 57
febrile neutropenia (56) 56
filgrastim (54) 54
granulocyte colony-stimulating factor (52) 52
middle aged (51) 51
quality-of-life (50) 50
aged (48) 48
placebo-controlled trial (48) 48
breast-cancer (47) 47
non-hodgkins-lymphoma (47) 47
receiving chemotherapy (47) 47
care and treatment (46) 46
single-administration pegfilgrastim (44) 44
hematology (43) 43
adult (42) 42
pharmacology & pharmacy (40) 40
recombinant proteins (39) 39
pegfilgrastim (38) 38
anemia - drug therapy (37) 37
cell lung-cancer (37) 37
recombinant-human-erythropoietin (37) 37
granulocyte colony-stimulating factor - therapeutic use (36) 36
medicine & public health (36) 36
polyethylene glycols (36) 36
treatment outcome (34) 34
health care sciences & services (33) 33
anemia (32) 32
risk factors (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (31) 31
daily filgrastim (31) 31
quality of life (31) 31
neoplasms - complications (30) 30
antineoplastic agents - therapeutic use (29) 29
epoetin-alpha (28) 28
erythropoietin - therapeutic use (28) 28
neutropenia - chemically induced (28) 28
receiving myelosuppressive chemotherapy (27) 27
research (26) 26
darbepoetin alfa (24) 24
erythropoietin (24) 24
induced febrile neutropenia (24) 24
cancer patients (23) 23
g-csf (23) 23
anemia - chemically induced (22) 22
darbepoetin-alpha (22) 22
nursing (22) 22
rehabilitation (22) 22
anemia - etiology (21) 21
drug therapy (21) 21
erythropoietin - analogs & derivatives (21) 21
adolescent (20) 20
cancer-patients (20) 20
granulocyte colony-stimulating factor - administration & dosage (20) 20
hematinics - therapeutic use (20) 20
chemotherapy-induced neutropenia (19) 19
drug administration schedule (19) 19
medicine, general & internal (19) 19
mortality (19) 19
neutropenia - drug therapy (19) 19
neutropenia - prevention & control (19) 19
solid tumors (19) 19
granulocyte colony-stimulating factor - adverse effects (18) 18
multicenter (18) 18
pain medicine (18) 18
phase-iii trial (18) 18
recombinant proteins - therapeutic use (18) 18
rehabilitation medicine (18) 18
retrospective studies (18) 18
chemotherapy-induced anemia (17) 17
health aspects (17) 17
phase-iii (17) 17
risk (17) 17
anaemia (16) 16
chemotherapy-induced febrile neutropenia - prevention & control (16) 16
child (16) 16
internal medicine (16) 16
nursing management/nursing research (16) 16
breast cancer (15) 15
prospective studies (15) 15
analysis (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
cancer therapies (14) 14
clinical trials as topic (14) 14
colony-stimulating factors (14) 14
cost-effectiveness (14) 14
lymphomas (14) 14
prophylaxis (14) 14
stem-cell transplantation (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Wiener klinische Wochenschrift, ISSN 0043-5325, 4/2016, Volume 128, Issue 7, pp. 238 - 247
To describe the incidence of febrile neutropenia (FN) and use of pegfilgrastim in cancer patients with high overall risk of FN and to investigate the... 
Chemotherapy | Observational study | Pneumology/Respiratory System | Medicine & Public Health | Granulocyte colony-stimulating factor | Gastroenterology | Internal Medicine | Medicine/Public Health, general | Endocrinology | Neoplasms | Febrile neutropenia | ADJUVANT CHEMOTHERAPY | MORTALITY | PEGFILGRASTIM PRIMARY PROPHYLAXIS | COLONY-STIMULATING FACTOR | FILGRASTIM | DELIVERY | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | IMPACT | CLINICAL-PRACTICE | PATIENTS RECEIVING CHEMOTHERAPY | Europe, Eastern - epidemiology | Neutropenia - epidemiology | Humans | Middle Aged | Granulocyte Colony-Stimulating Factor - standards | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Male | Filgrastim | Incidence | Dose-Response Relationship, Drug | Aged, 80 and over | Recombinant Proteins - standards | Adult | Female | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Polyethylene Glycols | Guideline Adherence - utilization | Risk Factors | Austria - epidemiology | Treatment Outcome | Recombinant Proteins - administration & dosage | Neoplasms - drug therapy | Neutropenia - prevention & control | Aged | Neoplasms - epidemiology | Granulocyte Colony-Stimulating Factor - administration & dosage | Lung cancer | Oncology, Experimental | Macrophage colony stimulating factor | Research | Drug therapy | Health aspects | Hyperthermia | Risk factors | Fever | Neutropenia | Cancer | Original
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 12/2017, Volume 15, Issue 12, pp. 1520 - 1520
Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This... 
CELL LUNG-CANCER | CHEMOTHERAPY-INDUCED NEUTROPENIA | COLONY-STIMULATING FACTOR | INDUCED PULMONARY TOXICITY | ONCOLOGY | NON-HODGKINS-LYMPHOMA | CAPILLARY-LEAK SYNDROME | INDUCED FEBRILE NEUTROPENIA | RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY | SPONTANEOUS SPLENIC RUPTURE | CONTROLLED PHASE-III
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 10/2018, Volume 104, Issue 4, pp. 742 - 748
The aim of the study was to evaluate the quantitative relationship between duration of severe neutropenia (DSN, the efficacy endpoint) and area under effect... 
CELL LUNG-CANCER | COLONY-STIMULATING FACTOR | PHARMACODYNAMIC MODEL | HEALTHY-SUBJECTS | SINGLE-ADMINISTRATION PEGFILGRASTIM | DOUBLE-BLIND | DRUG DEVELOPMENT | PHARMACOLOGY & PHARMACY | INDUCED FEBRILE NEUTROPENIA | RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY | CLINICAL-PRACTICE
Journal Article
The Oncologist, ISSN 1083-7159, 04/2018, Volume 23, Issue 4, pp. 403 - 409
Journal Article
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 12/2015, Volume 15, Issue 12, pp. 1799 - 1817
Journal Article
Journal Article